tirzepatide weight loss clinics near me Injections & You GLP-1 Tirzepatide for Weight Loss

Randomized clinical trial (2025): A double-blind RCT found once-weekly semaglutide reduced alcohol craving and heavy drinking versus placebo in adults with AUD, supporting larger confirmatory trials

Omzo's own refund policy confirms the intake process is genuinely clinical: patients who are medically disqualified by a provider during the initial consultation receive a full refund

Brand-name Wegovy and Zepbound are sometimes covered for patients with documented obesity (BMI 30+) or BMI 27+ with a comorbid condition

The Gallup survey found that 66 percent of patients who switched from brand-name to compounded GLP-1 versions cited cost as the primary reason, and 34 percent cited insurance coverage problems